Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study

Eitemau Tebyg

• Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2)
  gan: Miura, Hiroshi, et al.
  Cyhoeddwyd: (2018)
• Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
  gan: Nakamura, Tomoaki, et al.
  Cyhoeddwyd: (2014)
• Pancreatic fat content assessed by (1)H magnetic resonance spectroscopy is correlated with insulin resistance, but not with insulin secretion, in Japanese individuals with normal glucose tolerance
  gan: Komada, Hisako, et al.
  Cyhoeddwyd: (2017)
• Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes
  gan: Heise, Tim, et al.
  Cyhoeddwyd: (2017)
• Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements
  gan: Pearson, Scott M., et al.
  Cyhoeddwyd: (2018)